Repaglinide
CAS 135062-02-1
Overview
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus
Anant Labs manufacture and furnish high quality Repaglinide impurities for global markets. Our Repaglinide EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS135062-02-1
Mol. FormulaC27H36N2O4
Mol. Weight452.595 g/mol
IUPAC2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid
SMILESCCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
InChIInChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1
InChI KeyFAEKWTJYAYMJKF-QHCPKHFHSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
Repaglinide135062-02-1PrandinGlucoNormRepaglinidaAG-EE 623 ZWRepaglinidumAG-EE 388 ZWAGEE-623ZWAG-EE-623ZW
